French Food Stock News

ENXTPA:RF
ENXTPA:RFDiversified Financial

Eurazeo (ENXTPA:RF) Valuation Revisited After Prolonged Share Price Weakness And Mixed Momentum

Eurazeo (ENXTPA:RF) has drawn investor attention after a period of weak share performance, with the stock showing negative returns over the past month, past 3 months and year. This has raised questions about how its valuation aligns with its fundamentals. See our latest analysis for Eurazeo. The recent 1 month share price return of 23.98% and year to date share price return of a 27.56% decline, alongside a 1 year total shareholder return of a 45.31% decline, point to fading momentum as...
ENXTPA:ALO
ENXTPA:ALOMachinery

Alstom’s New Contracts Test Services Growth Versus Stretched Valuation Concerns

Alstom (ENXTPA:ALO) has secured a €380 million contract to upgrade and extend maintenance for the Skyway automated people mover at Houston Intercontinental Airport. The company has also signed a long-term support and refurbishment agreement for ScotRail's Class 222 fleet. Both agreements add multi year visibility to Alstom's services activity across North America and the UK rail markets. Alstom focuses on rail and mobility solutions, including rolling stock, signaling and long term...
ENXTPA:AKE
ENXTPA:AKEChemicals

Arkema Expands China PVDF Capacity As Battery Materials Story Evolves

Arkema announced a 20% expansion of its Kynar PVDF manufacturing capacity at its Changshu site in China. The new capacity targets demand from electric vehicle batteries, energy storage and high tech applications across Asia Pacific. The news highlights Arkema's focus on advanced materials for the energy transition. For investors watching Arkema (ENXTPA:AKE), this move comes with the shares trading around €54.3 and showing mixed recent performance. The stock is up 3.7% year to date, but has...
ENXTPA:STMPA
ENXTPA:STMPASemiconductor

STMicroelectronics China STM32 Shift Meets Mixed Valuation And Momentum Signals

STMicroelectronics (ENXTPA:STMPA) has started fully localized STM32 microcontroller production in China through a new partnership with Huahong. The arrangement establishes a complete local supply chain in China, from wafer manufacturing to assembly and testing. This development is positioned as a key step for the company’s operations in the Chinese electronics manufacturing ecosystem. STMicroelectronics, trading at around €27.51, has recorded a 17.4% gain year to date and a 24.1% return...
ENXTPA:VIE
ENXTPA:VIEIntegrated Utilities

A Look At Veolia Environnement’s (ENXTPA:VIE) Valuation As Karviná Plant Enters Final Coal Exit Phase

Veolia Environnement (ENXTPA:VIE) has moved into the final stage of transforming its Karviná heating plant, targeting a complete coal exit by 2029 while serving roughly 50,000 households with a multi-energy cogeneration setup. See our latest analysis for Veolia Environnement. Veolia's progress at Karviná comes as the share price sits at €31.67, with a 30 day share price return of an 8% decline, contrasting with a 90 day share price return of 8.16% and a 5 year total shareholder return of...
ENXTPA:ABCA
ENXTPA:ABCADiversified Financial

ABC Arbitrage (ENXTPA:ABCA) Half Year EPS Jump Challenges Longstanding Earnings Weakness Narrative

ABC arbitrage (ENXTPA:ABCA) posts higher first half revenue with solid EPS contribution ABC arbitrage (ENXTPA:ABCA) has reported first half FY 2025 revenue of €36.6 million with basic EPS of €0.30, setting the tone for a set of results anchored by higher trailing 12 month revenue of €65.1 million and EPS of €0.60. Over recent periods, revenue has moved from €22.9 million in the first half of 2024 to €28.6 million in the second half and now €36.6 million in the first half of 2025, while basic...
ENXTPA:ABVX
ENXTPA:ABVXBiotechs

ABIVAX (ENXTPA:ABVX) EPS Loss Of €2.10 In Q3 Reinforces Bearish Narratives

ABIVAX Société Anonyme (ENXTPA:ABVX) has reported FY 2025 third quarter revenue of €0.639 million and a basic EPS loss of €2.10, while trailing twelve month figures show revenue of €5.311 million and a basic EPS loss of €4.46. Over recent quarters, revenue has moved from €1.351 million in Q3 2024 to €0.97 million in Q1 2025 and €1.047 million in Q2 2025, with basic EPS losses of €0.87, €0.83 and €0.76 across those same periods, and a trailing net loss of €293.52 million anchoring the story...
ENXTPA:RUI
ENXTPA:RUIGas Utilities

Assessing Rubis (ENXTPA:RUI) Valuation After Softer 2025 Earnings And A Higher Dividend Proposal

Earnings and dividend proposal put Rubis in focus Rubis (ENXTPA:RUI) has drawn fresh attention after reporting full year 2025 results, showing slightly lower sales and net income, while at the same time proposing a higher dividend per share for shareholders. See our latest analysis for Rubis. The share price reaction around the earnings and dividend news has been mixed, with a 1-day share price return of 1.09% but a 30-day share price return decline of 7.45%, while the 1-year total...
ENXTPA:GLE
ENXTPA:GLEBanks

Assessing Société Générale (ENXTPA:GLE) Valuation After Completing A €1.5b Share Buyback Program

Société Générale Société anonyme (ENXTPA:GLE) has completed a share buyback, repurchasing 20,964,286 shares, about 2.78% of its capital, for €1,467.83 million, a move that directly affects remaining shareholders. See our latest analysis for Société Générale Société anonyme. Despite the €1.4b buyback and recent bond issue, the share price has been under pressure in the short term, with a 1 month share price return decline of 13.88% and a year to date share price return decline of 9.36%. At the...
ENXTPA:BN
ENXTPA:BNFood

Assessing Danone (ENXTPA:BN) Valuation As Fair Value Models Clash With Rich Market Multiples

With no specific headline event driving attention today, Danone (ENXTPA:BN) is drawing interest as investors reassess its recent share performance and fundamentals, including revenue of €27.3b and net income of €1.8b. See our latest analysis for Danone. At a share price of €68.32, Danone’s recent trend shows weaker short term momentum, with a 30 day share price return of 7.17% and a 90 day return of 11.13%. The 5 year total shareholder return of 37.25% points to a steadier long run...
ENXTPA:ELIS
ENXTPA:ELISCommercial Services

Elis Taps €600 Million Bond To Rebalance Debt And Fund Buybacks

Elis (ENXTPA:ELIS) has priced €600 million in senior unsecured notes under its EMTN programme. The funds are intended for debt refinancing and a new share buyback program. The placement was strongly oversubscribed, indicating solid demand from investors. Elis, a provider of textile, hygiene and facility services, operates in sectors where clients often rely on long term outsourcing contracts, from hospitality and healthcare to industry. Recent years have kept attention on operational...
ENXTPA:CA
ENXTPA:CAConsumer Retailing

Carrefour (ENXTPA:CA) Valuation Check As Recent Pullback Meets Conflicting Analyst Signals

Why Carrefour stock is drawing attention now Carrefour (ENXTPA:CA) is back on many investors’ screens after recent share price moves, with the stock showing a mix of shorter term weakness and longer term strength across different time frames. See our latest analysis for Carrefour. The recent pullback, including a 1-day share price return of a 1.57% decline and a 7-day share price return of a 4.40% decline, sits against a 1-year total shareholder return of 26.84%. This suggests momentum has...
ENXTPA:AIR
ENXTPA:AIRAerospace & Defense

Assessing Airbus (ENXTPA:AIR) Valuation After Recent Share Price Momentum Shifts

Why Airbus stock is back on investors’ radar Airbus (ENXTPA:AIR) has caught investor attention after a period where the share price shows mixed recent returns, including a 3.4% gain over the past day and a decline over the past month. See our latest analysis for Airbus. The recent 1 day share price return of 3.41% comes after a weaker spell, with the 30 day share price return of 12.30% and year to date share price return of 18.31%. In contrast, the 5 year total shareholder return of 82.84%...
ENXTPA:VIV
ENXTPA:VIVEntertainment

Assessing Vivendi (ENXTPA:VIV) Valuation After Earnings Return To Profit And Dividend Confirmation

Vivendi earnings and dividend move into focus Vivendi (ENXTPA:VIV) has just reported full year 2025 earnings alongside a proposed ordinary dividend of €0.04 per share, bringing both profitability and cash distributions onto investors’ radar. See our latest analysis for Vivendi. Despite reporting a move from a net loss to net income and putting a cash dividend back on the table, Vivendi’s 30 day share price return of 23.16% and 1 year total shareholder return of 38.66% both remain weak. This...
ENXTPA:ADP
ENXTPA:ADPInfrastructure

A Look At Aeroports de Paris (ENXTPA:ADP) Valuation As Passenger Traffic Trends Higher

Traffic uptick puts Aeroports de Paris in focus Aeroports de Paris (ENXTPA:ADP) has come into focus after reporting group traffic of 26,664,481 passengers for February 2026, up 5.0%, and 56,169,552 year to date, up 2.9%, indicating a pickup in passenger volumes. See our latest analysis for Aeroports de Paris. The February traffic update arrives after a mixed share price run, with Aeroports de Paris posting a 1 day share price return of 0.58% but a 30 day share price return decline of 12.56%...
ENXTPA:TTE
ENXTPA:TTEOil and Gas

TotalEnergies Shifts U.S. Capital From Offshore Wind To Gas And LNG

TotalEnergies is exiting the U.S. offshore wind sector and giving up key leases following an agreement with the U.S. government. The company plans to redirect nearly $1b from planned offshore wind projects to U.S. gas and LNG activities. The decision represents a change in how TotalEnergies allocates capital across its U.S. energy portfolio. For investors watching ENXTPA:TTE, this move comes with the stock at €76.0 and strong multi year returns, up 35.5% year to date, 39.4% over 1 year and...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Sanofi Immunology Advances Test Long Term Case Beyond Recent Share Weakness

Sanofi has entered a global licensing agreement with Kali Therapeutics for KT501, a tri specific T cell engager for autoimmune diseases currently in clinical trials for rheumatoid arthritis. Dupixent has received regulatory approval in Japan for moderate to severe bullous pemphigoid, a rare and serious dermatologic condition with limited treatment options. These developments expand Sanofi's immunology and rare disease franchises, highlighting progress in first in class and best in class...
ENXTPA:SK
ENXTPA:SKConsumer Durables

Assessing SEB (ENXTPA:SK) Valuation After Removal From The FTSE All-World Index

SEB (ENXTPA:SK) has been removed from the FTSE All-World Index, a change that can influence investor flows as index-tracking funds adjust positions and reassess their exposure to the French home appliance group. See our latest analysis for SEB. SEB's removal from the FTSE All-World Index comes after a sharp 16.74% 1 month share price return decline and a 49.74% 1 year total shareholder return loss, pointing to fading momentum as index related selling meets already weak sentiment. If this kind...
ENXTPA:MC
ENXTPA:MCLuxury

LVMH Expands European Flagships As Beauty Leadership Shifts Test Resilience

LVMH Moët Hennessy - Louis Vuitton Société Européenne is expanding its physical retail footprint across Europe with new and enlarged flagship stores. The group is committing to premium, immersive retail locations at a time of cautious luxury demand and higher rental costs. LVMH is competing with major rivals for prime high street and shopping district sites in key European cities. For investors following ENXTPA:MC, this renewed focus on physical retail comes as the share price stands at...
ENXTPA:CAP
ENXTPA:CAPIT

Is Capgemini (ENXTPA:CAP) Now Appealing After A 31% Twelve-Month Share Price Slide?

Investors may be wondering whether Capgemini at €98.24 is starting to look interesting again, or if the current price still feels rich for the risk involved. The stock has fallen 6.5% over the last week, 6.0% over the last month, and is down 30.2% year to date and 31.4% over the past year, which will catch the eye of anyone watching for potential value or a further shift in risk sentiment. Recent coverage has focused on how sustained share price weakness has put more attention on...
ENXTPA:OR
ENXTPA:ORPersonal Products

Is It Time To Reassess L'Oréal (ENXTPA:OR) After The Recent 14% Share Price Slide?

Investors may be wondering whether L'Oréal's current share price reflects its true worth, or if the market is mispricing this beauty giant. The stock last closed at €344.90, with a 14.0% decline over the past 30 days and a smaller 2.0% pullback in the last week. Over a 1 year period the return sits at 0.6%, and over 5 years the return stands at 13.6%. Recent coverage around L'Oréal has focused on its position as a global consumer brand and how investor sentiment has been adjusting in...
ENXTPA:STMPA
ENXTPA:STMPASemiconductor

Is It Time To Reassess STMicroelectronics (ENXTPA:STMPA) After Recent Share Price Pullback?

Wondering whether STMicroelectronics is offering good value at its current price, or if the recent run has already done the heavy lifting for you? The stock closed at €27.00, with a 7 day return of 8.1% decline and a 30 day return of 5.4% decline, but is still up 15.2% year to date and 21.9% over the last year, while the 3 year and 5 year returns sit at 39.3% decline and 11.7% decline. Recent headlines around STMicroelectronics have focused on its role in the broader semiconductor supply...
ENXTPA:ERF
ENXTPA:ERFLife Sciences

Eurofins Scientific (ENXTPA:ERF) Valuation Check After Recent Share Price Pullback

Eurofins Scientific and recent share performance Eurofins Scientific (ENXTPA:ERF) has drawn investor attention after recent share moves, including a roughly 10% decline over the past month. This has prompted closer inspection of its fundamentals and valuation signals. See our latest analysis for Eurofins Scientific. Despite the recent 10% 30 day share price decline and a modest year to date share price fall of 2%, Eurofins Scientific’s 1 year total shareholder return of 21.48% points to...